The statistics landing in early 2025 did not read like the kind of data that gets buried in a press release. Cancer rates among women under 50 in the United States are now 83 percent higher than among men in the same age group – a gap that has widened dramatically over the past two decades, and one that researchers at some of the country’s most prominent institutions are still struggling to explain. For a generation of women who were largely told that cancer was a concern for later in life, the numbers represent something of a reckoning.
What makes the picture more unnerving is that it sits inside what should be a good-news story. Cancer mortality in the United States has been falling for decades. Treatment has improved. Detection has improved. And yet, within that broadly optimistic framework, a very specific and very alarming pattern has emerged: the women bearing the steepest rise in new cancer diagnoses are not older women. They are millennial women, born roughly between 1981 and 1996, who are now in their late 20s through mid-40s. The very cohort that should be benefiting most from modern medicine’s advances is the one driving this trend in the wrong direction.
The question of why this is happening does not have a clean answer. Researchers are actively pursuing several theories, ranging from diet and environmental exposures to reproductive patterns and the biology of specific cancer subtypes. What follows is an examination of the data as it currently stands – what is known, what is suspected, and what it means for the millions of millennial women who may not yet know they are at elevated risk.
The Numbers Behind the Headline
The cancer incidence rate for women younger than 50 has increased from 51 percent higher than men in 2002 to 82 percent higher in 2021, which represents the most current year for which data is available. The figure cited in the article title – 83 percent – comes from a separate Washington Post analysis of federal data covering ages 15 through 49, using National Cancer Institute SEER data. Cancer rates among those aged 15 to 49 have increased by 10 percent since 2000 even as they have fallen among older people, and young women are more affected than men – from ages 15 through 49, women have a cancer rate that is 83 percent higher than men in the same age range.
The source behind the most widely cited version of the figure is the American Cancer Society’s Cancer Statistics, 2025 report, published in January 2025 in the journal CA: A Cancer Journal for Clinicians. The ACS report found that the cancer mortality rate declined by 34 percent from 1991 to 2022 in the United States, averting approximately 4.5 million deaths – but that this progress is threatened by increasing incidence for many cancer types, especially among women and younger adults. Incidence rates in women 50 to 64 have surpassed those in men, and rates in women under 50 are now 82 percent higher than their male counterparts, up from 51 percent in 2002.
Men historically had a higher overall cancer incidence than women, but in 2021, women younger than 50 surpassed them. To put that in concrete terms: in 2022, for every young man who got cancer, about 1.5 young women did. Now that number is closer to 1.8.
Although cancer still predominantly affects people 65 and older, new cancer diagnoses among adults in that age range dropped from 61 percent in 1995 to 59 percent in 2021, while people between the ages of 50 to 64 – and people younger than 50 – saw increases.
Which Cancers Are Driving the Rise
The pattern is not uniform across all cancer types, and understanding which cancers are climbing fastest matters enormously for both research priorities and screening decisions.
Breast and thyroid cancers in women appear to be driving the increasing trend overall. “Breast and thyroid cancer account for almost half of all cancer diagnoses in women younger than 50,” said Rebecca Siegel, lead author of the ACS report and senior scientific director of surveillance research at the American Cancer Society.
Breast cancer in particular has been rising faster among women under 50 – up by 1.4 percent a year since the mid-2000s, compared to a 0.7 percent annual rise among older women. The change is driven in large part by an increase in breast cancer in women under 50, a statistic that researchers at institutions including the University of Colorado Cancer Center are actively studying.
Beyond breast and thyroid cancer, the ACS report also found that lung cancer rates in women younger than 65 surpassed men in the same age group. This is partly due to differences in women starting smoking and quitting, the report noted.
Then there is the colorectal cancer picture, which has been one of the most documented and disturbing trends in oncology over the past decade. The number of colorectal cancer cases is increasing at an alarming rate for Generation Z, millennials, and Generation X. According to a 2023 American Cancer Society report, colorectal cancer cases among adults younger than 55 increased from 11 percent in 1995 to 20 percent in 2019. People born after the 1980s are four times more likely to be diagnosed with rectal cancer than those born around 1950.
Mortality trends also increased in conjunction with the incidence of liver cancer (in females only), uterine corpus, gallbladder, testicular, and colorectal cancers. Uterine cancer deserves particular attention. Rising rates of uterine cancer, combined with stagnating or worsening survival outcomes, have made it one of the more alarming entries on the list of cancers climbing in younger women.
The Generational Pattern
Understanding why millennial women are disproportionately affected requires looking beyond individual risk factors and examining the generational context these numbers sit in.
One large study published in The Lancet Public Health in July 2024 analyzed differences among adults born in the United States between 1920 and 1999, and found incidence rates rose in successively younger generations – particularly in Generation Xers and Millennials – in 17 of 34 cancer types, including breast, pancreatic, and gastric cancers. Mortality rates for several cancer types increased as well. The study was led by the American Cancer Society.
While combing through epidemiological data, cancer epidemiologist Caitlin Murphy of the University of Chicago noticed a curious trend: the rise in cancer diagnoses tracked with birth year. Rather than a gradual, age-driven climb across all cohorts, cancer rates appeared to spike specifically among millennials. The pattern, Murphy realized, was about a birth cohort – a group of people born during the same period.
That cohort framing matters. It moves the analytical lens away from individual behaviors and toward shared exposures – things that one generation encountered at a formative developmental stage that previous generations did not encounter to the same degree, or at the same windows of vulnerability.
Cancer rates are sometimes two to three times higher in incidence for the Gen X and Millennial population compared to Baby Boomers, according to ACS CEO Dr. Karen Knudsen, speaking to PBS News Hour. That spread is not explained by genetics alone. The human genome does not change meaningfully across three generations. The environment does.
What Researchers Suspect Is Driving It
Ultra-Processed Foods and the Dietary Shift
One of the most actively investigated potential contributors is the change in diet that accelerated precisely as millennials were growing up. In the last several decades, consumption of ultra-processed foods has soared throughout the world. Today, more than half of the calories Americans eat comes from ultra-processed foods.
The connection to cancer risk is not hypothetical. Eating more ultra-processed foods is tied to an increased risk of precancerous colorectal growths in women under 50, according to a study published in JAMA Oncology in November 2025. These growths, called adenomas or polyps, can later turn into cancer and are a good indicator of a person’s cancer risk, experts say. Rates of colorectal cancer in people under 50 have risen sharply in recent decades.
Researchers at Massachusetts General Hospital, led by gastroenterologist Dr. Andrew Chan, have been pursuing this question through a global research initiative launched in 2024 to investigate the surge in colon cancer among young adults. His team presented early findings suggesting a troubling link: individuals under 50 who consumed the largest quantities of ultra-processed foods faced a 1.5-fold increased risk of developing early-onset colon tumors.
Recent scientific research shows that eating ultra-processed foods raises cancer risk, especially for colorectal, ovarian, breast, and brain cancers. Examining 11 studies, researchers found that a 10 percent increment in the diet’s proportion of ultra-processed food was associated with increased risk of overall cancer and breast cancer. High intake was also associated with increased risk of colorectal and pancreatic cancer.
Reproductive and Hormonal Factors
A main contributor to the higher incidence rate is breast cancer, which predominantly affects women. Higher obesity rates, increased alcohol use, and later-in-life pregnancies have long been identified as risk factors for breast cancer, though researchers acknowledge there are still many unknowns.
Millennial women have, as a cohort, delayed childbearing compared to previous generations – and the biological relationship between pregnancy timing, breastfeeding duration, and breast cancer risk is well-established. Later first pregnancies and lower breastfeeding rates both reduce the hormonal protective effects that earlier and longer reproductive activity can confer. These are not moral judgments about life choices; they are biological mechanisms that epidemiologists track because they influence population-level risk.
As Maurie Markman, MD, President of Medicine & Science at City of Hope Cancer Centers, put it: “The increase in cancers observed in younger women is concerning. Several hypotheses can be advanced to partially explain the data, including later childbearing, changes in tobacco and alcohol consumption among women, and the staggering increase” in other contributing factors.
Environmental and Industrial Exposures
Beyond diet and reproductive patterns, a third category of investigation involves the broader chemical environment that millennials grew up in – one defined by a postwar industrial expansion that filled food, plastics, personal care products, and water systems with compounds whose long-term biological effects were never fully assessed before widespread use.
Prenatal exposures, environmental toxins, and various lifestyle factors are under active investigation as potential contributors to the alarming trend in early-onset cancer among younger generations, according to researchers at Memorial Sloan Kettering Cancer Center. The role of prenatal chemical exposure is particularly hard to study, because the exposures in question occurred before the affected individuals were born, in some cases before their mothers were fully aware of the substances involved.
What is clear is that the pattern across cancer types does not conform to a single known risk factor. The cause of this trend is not clear. It is complex and varies depending on the type of cancer, according to researchers at Dana-Farber Cancer Institute. That complexity is part of what makes the search for answers so difficult – and so urgent.
A Global Problem With a Millennial Concentration
This is not exclusively an American phenomenon. The rise in early-onset cancer incidence is not limited to the United States; it is a global phenomenon. The global burden of early-onset cancer incidence surpassed 3.26 million in 2019, a 79.1 percent increase from the incidence in 1990.
Compared with 2019, the global incidence of early-onset cancers is projected to rise by 31 percent by 2030, and deaths will go up by 21 percent. Millennials and Gen Zers will carry disproportionate cancer risks with them as they age, “potentially slowing decades of progress against cancer.”
The global nature of the trend suggests that whatever is driving it is not limited to American dietary habits or the American healthcare system. It appears instead to reflect shared conditions of postindustrial life that have touched comparable economies across the world: processed food systems, sedentary work and leisure patterns, widespread chemical use, and delayed reproductive timing.
Racial Disparities Within the Trend
Any honest accounting of this data has to address the fact that the burden of rising cancer rates is not distributed equally across racial groups. The ACS data consistently demonstrates that cancer mortality disparities by race and ethnicity are severe and, in many cases, widening.
American Indian and Alaska Native people are two to three times more likely to die from cancers of the cervix, kidney, liver, and stomach compared to White people. Black people are twice as likely to die from prostate, stomach, and uterine cancer than White people.
These disparities are not explained by biology. They are the product of differential access to screening, differential quality of care, higher rates of exposure to environmental risk factors in residential environments, and well-documented patterns of having symptoms dismissed or delayed in diagnosis – a pattern that the broader data on under-50 cancer diagnosis reflects as well. When clinicians and researchers talk about the surprising rise in cancer among young women, they are often describing a population that is already navigating a medical system that has historically treated them as lower-risk. That assumption is now explicitly contradicted by the data.
Read More: People with cancer or HIV could lose Medicaid under new work rules
What This Means for Screening
The rise in early-onset cancers has already begun to reshape clinical guidelines, though the changes have come slowly and may not yet have reached the physicians that younger women are most likely to see.
The American Cancer Society dropped its recommendation for a first colonoscopy from age 50 to age 45, explicitly because of trends in early-onset colorectal cancer. Clinicians now typically recommend starting colonoscopy screening 10 to 15 years before the age at which a first-degree relative was diagnosed with colorectal cancer. Similarly, women who are at average risk for breast cancer may now start biennial mammography screening at age 40, according to U.S. Preventive Services Task Force recommendations updated in 2024.
Women with a family history of breast cancer are generally advised to start when they are 10 years younger than the first-degree relative who was diagnosed.
For millennial women, the practical implication is that both breast and colorectal cancer screening is now recommended at ages that would have been considered aggressive or unnecessary 15 years ago. Women in their late 30s and early 40s who have not yet had a baseline colonoscopy or who have been told a mammogram can wait until 50 should understand that the guidance has changed – and that the physician who gave them the older advice was not wrong at the time, but the evidence has since moved.
The diagnostic delay problem is also real. Women younger than 50 who report symptoms have documented experiences of not being taken seriously by clinicians because of their age. One woman quoted in CNN’s reporting on the ACS data described being told for months that something wasn’t right, only to finally receive a breast cancer diagnosis after pushing for a mammogram. That experience is not rare. It is, in fact, one of the recurring themes in the qualitative data on early-onset cancer in young women: that the absence of perceived risk in younger patients contributes to longer diagnostic timelines and later-stage diagnoses.
Key Takeaways
The data assembled across the American Cancer Society’s 2025 report, the July 2024 Lancet Public Health generational study, the Washington Post’s federal data analysis, and the ongoing research at institutions from Harvard to MSK to Dana-Farber points toward several conclusions that are worth holding together rather than individually.
Cancer rates among millennial women are rising in a way that cannot be attributed to a single cause. The 83 percent gap between cancer incidence in young women and young men – compared to a 51 percent gap just two decades ago – reflects a convergence of biological, behavioral, environmental, and systemic factors that researchers are still separating from one another. No one knows exactly what the cause is, but the scientific community has strong indications that environmental factors are centrally involved.
The framing of this trend as a “women’s health issue” in the narrow sense is itself part of the problem. The rise in cancer diagnoses tracks with birth year, and rates appear to spike specifically among millennials – which means the forces driving it are generational and shared, not simply biological. A generation that grew up consuming more ultra-processed food than any prior one, in an environment saturated with industrial chemicals whose cumulative effects remain poorly studied, is now in the age window where those exposures may be expressing themselves as elevated cancer risk. That is not a hypothesis. It is, increasingly, the working theory of the researchers closest to the data.
Global early-onset cancer incidence is projected to rise by 31 percent from 2020 to 2030, and deaths by 21 percent. Millennials and Gen Zers will carry disproportionate cancer risks with them as they age.
What to Do With This Information
The numbers are large enough and consistent enough that they warrant something more than concern. They warrant action – specifically, the kind of action that does not require waiting for medicine or policy to catch up.
For millennial women in their late 30s and early 40s, the most immediate implication is about screening timelines that have already changed. The old threshold of 50 for a first colonoscopy and the assumption that mammograms could wait until a woman “felt at risk” have both been revised by the evidence. If a primary care physician is still working from the older guidelines, that conversation is worth having. The updated recommendations exist precisely because the data on early-onset cancer in this generation forced clinicians to rethink what lower-risk actually looks like. Younger does not mean lower-risk anymore, and the institutions tracking these numbers have said so explicitly.
The harder piece is the one that has no clean personal fix. The exposures that appear to be driving the generational pattern – prenatal chemical environments, decades of ultra-processed food, industrial compounds whose effects we are only now beginning to measure – are not things any individual woman could have avoided or can now undo. That reality does not make the data less urgent. If anything, it makes the case for earlier and more aggressive screening even clearer, because the factors outside any one person’s control make the factors within reach – getting screened, not letting a dismissed symptom go unchallenged, pushing for imaging when something feels wrong – all the more worth fighting for.
Disclaimer: This information is not intended to be a substitute for professional medical advice, diagnosis, or treatment and is for information only. Always seek the advice of your physician or another qualified health provider with any questions about your medical condition and/or current medication. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.